• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Malaria.com

Malaria Mosquitoes Reveal Pathogen Defense Strategies

March 22, 2011 By Malaria.com Leave a Comment

In analyzing malaria mosquitoes in sub-Saharan Africa, a Cornell-led team of researchers finds evidence of two very different evolutionary paths in the immune systems of neighboring mosquito groups. Genes in animal immune systems may evolve in one of two main ways in the constant fight against pathogens: They may evolve diverse forms of genes (alleles) to fight a wide variety of pathogens, or … [Read more...]

Filed Under: Malaria News Tagged With: Anopheles gambiae, Cornell, Pathogens, Sub-Saharan Africa

Canadian Researchers Develop Inexpensive Malaria Treatment

March 19, 2011 By Malaria.com Leave a Comment

Scientists in Saskatoon, Canada have developed a malaria treatment that will help fight malaria, which kills about one million people each year. The new developments which will provide an affordable, reliable, and stable treatment for malaria and is likely to save millions of lives, especially those of women and children in Africa. The Honourable Gary Goodyear, Minister of State for Science and … [Read more...]

Filed Under: Malaria News Tagged With: Amyris Inc., Artemisinin, Artemisinin-based Combination Therapies, Brad Trost, Gary Goodyear, Gates Foundation, Malaria Treatment, National Research Council Canada, OneWorld Health, Patrick Covello, Richard Chin, Sanofi-Aventis, U.C. Berkeley

Anacor Pharmaceuticals Enters Development Agreement with Medicines for Malaria Venture (MMV)

March 17, 2011 By Malaria.com 1 Comment

Anacor Pharmaceuticals has entered into a development agreement with Medicines for Malaria Venture (MMV) to develop Anacor’s compound AN3661 for the treatment of malaria. Under the agreement, Anacor and MMV will work together on the development of AN3661 through human proof-of-concept studies. AN3661 was developed as part of a research agreement signed by the two parties in April 2010 to … [Read more...]

Filed Under: Malaria News Tagged With: AN3661, Anacor Pharmaceuticals, David Perry, Eurartesim, Medicines for Malaria Venture (MMV), Pyramax

African Leaders Malaria Alliance Receives $250K Grant to Help Fight Malaria

March 15, 2011 By Malaria.com 1 Comment

The African Leaders Malaria Alliance (ALMA), an alliance of 39 African leaders, has been awarded a $250,000 grant to help with its campaign to combat malaria. ALMA, chaired by Tanzanian President Jakaya Kikwete and recently elected Deputy Chair, Ellen Johnson Sirleaf, President of Liberia, was launched in 2009 as a collaborative effort for African leaders to work together with the African … [Read more...]

Filed Under: Malaria News Tagged With: Ellen Johnson Sirleaf, ExxonMobil Foundation, Jakaya Kikwete, Johannah-Joy Phumaphi, Liberia, Tanzania, The African Leaders Malaria Alliance (ALMA), World Malaria Report 2010

Disease Burdens Shifting from Communicable to Chronic Diseases

March 14, 2011 By Malaria.com Leave a Comment

Those working for healthier humans around the globe are making headway in fighting communicable diseases such as AIDS, malaria and diarrheal illness, and researchers at the University of Denver have found that there is a transition occurring in global health from disease burdens due to communicable diseases to chronic ones such as cancer, diabetes and heart disease. "Because of great … [Read more...]

Filed Under: Malaria News Tagged With: AIDS, Barry Hughes, Chronic disease, Communicable Disease, Diarrheal Illness, Frederick S. Pardee Center for International Futures, University of Denver

Hoolywood Bites Back Fundraiser to Fight Malaria

March 8, 2011 By Malaria.com Leave a Comment

Conan O'Brien, Elizabeth Banks, B.J. Novak, and David Arquette are among the many comedians, musicians and public figures performing stand-up, sketches and musical acts when some of today's hottest stars from television, film and music will take the stage at the Nokia Theatre L.A. LIVE on April 16th for Hollywood Bites Back!, a night of comedy to benefit the nonprofit Malaria No More. "I am … [Read more...]

Filed Under: Malaria News Tagged With: B.J. Novak, Ed Helms, Elizabeth Banks, Ellie Kemper, Hollywood Bites Back, Jeremy Piven, John Mayer, Josh Groban, Lake Bell, Malaria No More, Nastasha Leggero, Nick Kroll, Orlando Bloom, Paul Sheer, Riki Lindhome, Ted Danson

Insecticide-Treated Mosquito Nets (ITMNs) Helps Prevent Japanese Encephalitis

March 8, 2011 By Malaria.com Leave a Comment

A new study reveals that using treated mosquito nets could drastically reduce the transmission of Japanese Encephalitis (JE) to humans. The study, conducted by the Regional Medical Research Centre (RMRC), Dibrugarh, North East Region (NE), Indian Council of Medical Research and released in the March issue of the American Journal of Tropical Medicine and Hygiene, showed that the use of … [Read more...]

Filed Under: Malaria News Tagged With: American Journal of Tropical Medicine and Hygiene, Bed Nets, Bednets, ITMN, Japanese Encephalitis, Lymphatic Filariasis, Mosquito Nets, Peter J. Hotez, Prafulla Dutta, Pyrethroids

APL1 Malaria Resistance Genes of Anopheles Gambiae

March 8, 2011 By Malaria.com Leave a Comment

Immune defense genes are sometimes highly variable in host populations, reflecting selective pressure to combat diverse pathogens. In other instances, where there are only a few dominant pathogens, natural selection may favor only one or a few defense alleles. Here, we show that both adaptive strategies can occur in the same genes under different circumstances. We examined diversity in the … [Read more...]

Filed Under: Malaria Research Tagged With: A. gambiae, Anopheles gambiae, APL1, Malaria Resistance, Susan M. Rottschaefer

Liquidia Technologies Gets $10M from Gates Foundation for Malaria Vaccine

March 4, 2011 By Malaria.com Leave a Comment

The Bill & Melinda Gates Foundation invested $10 million in Liquidia Technologies, a closely held biotechnology company developing vaccines, as part of a $400 million initiative to fund activities to help poorer countries. Liquidia is developing a seasonal flu vaccine and has an agreement with the PATH Malaria Vaccine Initiative to use its technology to work on new malaria vaccines, the … [Read more...]

Filed Under: Malaria News Tagged With: Gates Foundation, Liquidia Technologies, Malaria Vaccine, PATH Malaria Vaccine Initiative (MVI)

Inexpensive Lens-Free Mobile Phone Microscope May Improve Detection of Malaria

March 4, 2011 By Malaria.com Leave a Comment

Aydogan Ozcan, an associate professor of electrical engineering at UCLA, is working on a low-cost microscope that uses the silicon sensor found in mobile phone cameras. According to Ozcan, his microscope, which currently has a resolution of one millionth of a meter, which is powerful enough to reliably image the malaria parasite. While a traditional microscope can have a six-figure price tag, … [Read more...]

Filed Under: Malaria News Tagged With: Aydogan Ozcan, LUCAS, Mobile Phone Microscope

« Previous Page
Next Page »

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2025 Malaria.com · Log in